|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"yang ys"
Showing items 1-25 of 154 (7 Page(s) Totally)
1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2024-06-22 |
Imipenem reduces the efficacy of vancomycin against Elizabethkingia species
|
Yang, YS;Chen, HY;Lin, IC;Lin, MH;Wang, WY;Kuo, SC;Chen, WT;Cheng, YH;Sun, JR |
| 國家衛生研究院 |
2024-04-27 |
Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the diabetes association of the republic of China (Taiwan) and the Taiwanese association of diabetes educators
|
Shen, FC;Chu, CH;Chen, JF;Kuo, CS;Hsu, CY;Lin, CH;Sheen, YJ;Su, SC;Tien, KJ;Lu, CH;Lee, CC;Yang, YS;Tu, ST;Chen, PT;Chen, CC;Chien, MN;Li, HY;Sheu, WH;Huang, CN;Wang, CY;Ou, HY |
| 國家衛生研究院 |
2023-11-28 |
Elizabethkingia anophelis outer membrane vesicles as a novel vaccine candidate against infection: Insights into immune response and potential for passive immunity
|
Yang, YS;Chen, HJ;Chen, XC;Tang, HJ;Chang, FJ;Huang, YL;Pan, YL;Kesavan, DK;Chen, HY;Shang, HS;Kuo, SC;Chen, TL;Chiang, MH |
| 國家衛生研究院 |
2022-11-24 |
Trends in hospitalizations and emergency department visits among women with hyperglycemia in pregnancy between 2008 and 2017 in Taiwan
|
Wang, JS;Chin, MC;Chen, JF;Huang, CN;Hwu, CM;Ou, HY;Yang, YS;Hsu, CC;Wang, CY |
| 國家衛生研究院 |
2022-09-29 |
In vitro and in vivo efficacy of minocycline-based therapy for Elizabethkingia anophelis and the impact of reduced minocycline susceptibility
|
Yang, YS;Huang, TW;Huang, YC;Huang, WC;Hsu, SY;Wu, HC;Chen, FJ;Shang, HS;Sytwu, HK;Kuo, SC |
| 國家衛生研究院 |
2022-09-16 |
Biofilm formation is not an independent risk factor for mortality in patients with Acinetobacter baumannii bacteremia
|
Chiang, TT;Huang, TW;Sun, JR;Kuo, SC;Cheng, A;Liu, CP;Liu, YM;Yang, YS;Chen, TL;Lee, YT;Wang, YC |
| 國家衛生研究院 |
2022-08-09 |
Trends in all-cause mortality and major causes of death between 2007 and 2018 among patients with diabetes in Taiwan
|
Wang, JS;Wu, YL;Ou, HY;Yang, YS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2021-11-25 |
In vitro and in vivo comparison of eravacycline- and tigecycline-based combination therapies for tigecycline-resistant Acinetobacter baumannii
|
Yin, T;Lai, JJ;Huang, WC;Kuo, SC;Chiang, TT;Yang, YS;the ACTION study group |
| 國家衛生研究院 |
2021-04-13 |
Multicentre study of risk factors for mortality in patients with acinetobacter bacteraemia receiving colistin treatment[Erratum:International Journal of Antimicrobial Agents. 2020 Jun;55(6):Article number 105956.]
|
Lee, YT;Sun, JR;Wang, YC;Chiu, CH;Kuo, SC;Chen, TL;Yang, YS;the, ASG |
| 國家衛生研究院 |
2021-04-05 |
The prediction values of carbapenemase detection methods and carbapenem susceptibility testing for clinical outcomes of patients with Acinetobacter bacteremia under carbapenem treatment
|
Lee, YT;Huang, TW;Liu, IF;Kuo, SC;Yang, YS;Lin, PY;Liu, CP;Liu, YM;Chen, TL;Wang, FD;Wang, YC |
| 國家衛生研究院 |
2021-01-13 |
Cancer as an infectious disease: A different treatment alternative using a combination of tigecycline and pyrvinium pamoate - An example of breast cancer
|
Huang, SW;Sun, MT;Lee, WS;Su, YS;Lee, YT;Chiang, MH;Wang, YC;Yang, YS;Tzeng, SC;Huang, YM;Lin, FH |
| 國家衛生研究院 |
2021-01 |
Ser253Leu substitution in PmrB contributes to colistin resistance in clinical Acinetobacter nosocomialis
|
Yang, YS;Jeng, WY;Lee, YT;Hsu, CJ;Chou, YC;Kuo, SC;Chen, CC;Hsu, WJ;Chen, HY;Sun, JR |
| 中山醫學大學 |
2021 |
Effects of manufacturing procedures and preparation conditions on European Union priority polycyclic aromatic hydrocarbons in Oolong tea samples
|
Chiang, SM; Ueng, KC; Chen, HS; Wu, CJ; Yang, YS; Yang, DJ |
| 中山醫學大學 |
2021 |
Epidemiology and factors associated with mortality of thyroid storm in Taiwan: a nationwide population-based study
|
Kornelius, E; Chang, KL; Yang, YS; Huang, JY; Ku, MS; Lee, KY; Ho, SW |
| 國家衛生研究院 |
2020-10-31 |
Clinical and molecular characterization of Acinetobacter seifertii in Taiwan
|
Li, LH;Yang, YS;Sun, JR;Huang, TW;Huang, WC;Chen, FJ;Wang, YC;Kuo, TH;Kuo, SC;Chen, TL;Lee, YT;ACTION study group |
| 國家衛生研究院 |
2020-10-14 |
In vitro and in vivo activities of imipenem combined with BLI-489 against class D Beta-lactamase-producing Acinetobacter baumannii
|
Wang, YC;Huang, SW;Chiang, MH;Lee, IM;Kuo, SC;Yang, YS;Chiu, CH;Su, YS;Chen, TL;Wang, FD;Lee, YT |
| 國家衛生研究院 |
2020-09-29 |
Influence of severity of infection on the effect of appropriate antimicrobial therapy for Acinetobacter baumannii bacteremic pneumonia
|
Kang, FY;How, CK;Wang, YC;Cheng, A;Yang, YS;Kuo, SC;Liu, CP;Liu, YM;Chen, TL;Lee, YT |
| 國家衛生研究院 |
2020-04-09 |
Multicenter study of the risk factors for mortality in patients with acinetobacter bacteremia receiving colistin treatment
|
Lee, YT;Sun, JR;Wang, YC;Chiu, CH;Kuo, SC;Chen, TL;Yang, YS |
| 國家衛生研究院 |
2020-03-31 |
Confronting tigecycline-resistant acinetobacter baumannii via Immunization against conserved resistance determinants
|
Chiang, MH;Yang, YS;Sun, JR;Wang, YC;Kuo, SC;Lee, YT;Chuang, YP;Chen, TL |
| 國家衛生研究院 |
2020-02-11 |
Bacterial membrane vesicles from Acinetobacter baumannii induced by ceftazidime are more virulent than those induced by imipenem
|
Chiu, CH;Lee, YT;Lin, YC;Kuo, SC;Yang, YS;Wang, YC;Liu, YH;Lin, JC;Chang, FY;Chen, TL |
| 國家衛生研究院 |
2020-01-06 |
Is polymicrobial bacteremia an independent risk factor for mortality in acinetobacter baumannii bacteremia?
|
Wang, YC;Ku, WW;Yang, YS;Kao, CC;Kang, FY;Kuo, SC;Chiu, CH;Chen, TL;Wang, FD;Lee, AY |
| 中山醫學大學 |
2020 |
Optimal Initial Blood Pressure in Intensive Care Unit Patients with Non-Traumatic Intracranial Hemorrhage
|
Wei, MC; Kornelius, E; Chou, YH; Yang, YS; Huang, JY; Huang, CN |
| 中山醫學大學 |
2020 |
Osteoporosis and Stress Urinary Incontinence in Women: A National Health Insurance Database Study
|
Wei, MC; Chou, YH; Yang, YS; Kornelius, E; Wang, YH; Huang, CN |
| 中山醫學大學 |
2020 |
Use and effectiveness of dapagliflozin in patients with type 2 diabetes mellitus: a multicenter retrospective study in Taiwan
|
Chen, JF; Peng, YS; Chen, CS; Tseng, CH; Chen, PC; Lee, TI; Lu, YC; Yang, YS; Lin, CL; Hung, YJ; Chen, ST; Lu, CH; Yang, CY; Chen, CC; Lee, CC; Hsiao, PJ; Jiang, JY; Tu, ST |
| 中山醫學大學 |
2020 |
Executive summary of the DAROC clinical practice guidelines for diabetes care-2018 Diabetes Association of the Republic of China (Taiwan)
|
Chen, JF; Chen, HS; Chu, CH; Chuang, LM; Ho, LT; Hung, YJ; Kuo, CH; Li, HY; Lin, CH; Lin, KD; Lin, SY; Sheen, YJ; Sheu, WHH; Shin, SJ; Tsai, ST; Te Tu, S; Bai, CH; Chang, YC; Chang, TJ; Chang, CH; Chang, CJ; Chao, CC; Chen, CC; Chen, YL; Chong, K; Chuang, WL; Guo, LY; Hsieh, MC; Hsu, CC; Huang, LC; Huang, CN; Huang, YY; Hung, CS; Hung, WW; Hwu, CM; Jeng, JS; Jiang, YD; Juang, JMJ; Juang, JH; Kuo, CS; Kuo, JF; Kwok, CF; Lai, YC; Lee, MY; Lee, YJ; Lee, IT; Lee, CN; Lee, YT; Lee, TI; Lee, CH; Lin, LY; Lin, SD; Lin, KY; Lin, HJ; Lin, CH; Liu, CE; Lo, FS; Lu, CH; Lu, KC; Ma, WY; Ou, HY; Pei, D; Su, CC; Su, SL; Tan, ECH; Tien, KJ; Tsai, LK; Tseng, CH; Wang, JS; Weng, SF; Wu, WC; Yang, MC; Yang, YS; Yang, CH; Yang, WS; Yeh, JT; Yu, NC; Yu, TY |
Showing items 1-25 of 154 (7 Page(s) Totally)
1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
|
